Kentucky Statutes 311.645 – Definitions for KRS 311.645 to 311.647
Current as of: 2024 | Check for updates
|
Other versions
As used in KRS § 311.645 to KRS § 311.647:
(1) “Anaphylaxis” means an allergic reaction resulting from sensitization following prior contact with an antigen which can be a life-threatening emergency, including reactions triggered by, among other agents, foods, drugs, injections, insect stings, and physical activity;
(2) “Administer” means to directly apply an injectable epinephrine device to the body of an individual;
(3) “Asthma” means a respiratory condition marked by coughing, wheezing, or shortness of breath often triggered by allergies, exercise, or irritants;
(4) “Authorized entity” means an entity that may at any time have allergens present that are capable of causing a severe allergic reaction and has an individual who holds a certificate issued under KRS § 311.646 on the premises or officially associated with the entity. The term includes but is not limited to licensed child-care centers and certified family child-care homes, restaurants, recreation camps, youth sports leagues, theme parks and resorts, and sports arenas;
(5) “Bronchodilator rescue inhaler” means medication used to relieve asthma symptoms or respiratory distress along with devices and device components needed to appropriately administer the medication, including but not limited to disposable spacers;
(6) “Certified individual” means an individual who successfully completes an approved educational training program and obtains a certificate, as described in KRS
311.646;
(7) “Injectable epinephrine device” means a single-use device used to administer a premeasured dose of epinephrine;
(8) “Health-care practitioner” means a physician or other health-care provider who has prescriptive authority; and
(9) “Self-administration” means an individual’s administration of an injectable epinephrine device or bronchodilator rescue inhaler on herself or himself.
Effective: June 29, 2021
History: Amended 2021 Ky. Acts ch. 112, sec. 3, effective June 29, 2021. — Amended
2016 Ky. Acts ch. 122, sec. 2, effective July 15, 2016. — Created 2015 Ky. Acts ch.
113, sec. 29, effective June 24, 2015.
Legislative Research Commission Note (6/24/2015). 2015 Ky. Acts ch. 113, sec. 32 provides that this statute and KRS § 311.646 and KRS § 311.647 created in 2015 Ky. Acts ch.
113, secs. 29, 30, and 31 may be cited as the “Emergency Allergy Treatment Act.”
(1) “Anaphylaxis” means an allergic reaction resulting from sensitization following prior contact with an antigen which can be a life-threatening emergency, including reactions triggered by, among other agents, foods, drugs, injections, insect stings, and physical activity;
Terms Used In Kentucky Statutes 311.645
- Statute: A law passed by a legislature.
- Treatment: when used in a criminal justice context, means targeted interventions
that focus on criminal risk factors in order to reduce the likelihood of criminal behavior. See Kentucky Statutes 446.010
(2) “Administer” means to directly apply an injectable epinephrine device to the body of an individual;
(3) “Asthma” means a respiratory condition marked by coughing, wheezing, or shortness of breath often triggered by allergies, exercise, or irritants;
(4) “Authorized entity” means an entity that may at any time have allergens present that are capable of causing a severe allergic reaction and has an individual who holds a certificate issued under KRS § 311.646 on the premises or officially associated with the entity. The term includes but is not limited to licensed child-care centers and certified family child-care homes, restaurants, recreation camps, youth sports leagues, theme parks and resorts, and sports arenas;
(5) “Bronchodilator rescue inhaler” means medication used to relieve asthma symptoms or respiratory distress along with devices and device components needed to appropriately administer the medication, including but not limited to disposable spacers;
(6) “Certified individual” means an individual who successfully completes an approved educational training program and obtains a certificate, as described in KRS
311.646;
(7) “Injectable epinephrine device” means a single-use device used to administer a premeasured dose of epinephrine;
(8) “Health-care practitioner” means a physician or other health-care provider who has prescriptive authority; and
(9) “Self-administration” means an individual’s administration of an injectable epinephrine device or bronchodilator rescue inhaler on herself or himself.
Effective: June 29, 2021
History: Amended 2021 Ky. Acts ch. 112, sec. 3, effective June 29, 2021. — Amended
2016 Ky. Acts ch. 122, sec. 2, effective July 15, 2016. — Created 2015 Ky. Acts ch.
113, sec. 29, effective June 24, 2015.
Legislative Research Commission Note (6/24/2015). 2015 Ky. Acts ch. 113, sec. 32 provides that this statute and KRS § 311.646 and KRS § 311.647 created in 2015 Ky. Acts ch.
113, secs. 29, 30, and 31 may be cited as the “Emergency Allergy Treatment Act.”